Free Trial

Growth Stocks To Watch Today - May 3rd

Novo Nordisk A/S logo with Medical background

Novo Nordisk A/S, BlackRock, and Blackstone are the three Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares in companies expected to increase their revenues and earnings at a faster rate than the overall market. Investors buy them anticipating capital appreciation rather than current income, so these firms often reinvest profits instead of paying dividends. Because growth expectations are priced into their valuations, these stocks can be more volatile than the market average. These companies had the highest dollar trading volume of any Growth stocks within the last several days.

Novo Nordisk A/S (NVO)

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.

Shares of NYSE NVO traded up $3.67 during mid-day trading on Friday, reaching $69.27. The company had a trading volume of 13,447,464 shares, compared to its average volume of 6,216,064. The company has a current ratio of 0.74, a quick ratio of 0.55 and a debt-to-equity ratio of 0.62. Novo Nordisk A/S has a 52-week low of $57.00 and a 52-week high of $148.15. The firm has a 50 day simple moving average of $71.47 and a two-hundred day simple moving average of $87.99. The stock has a market cap of $310.85 billion, a P/E ratio of 21.05, a PEG ratio of 0.90 and a beta of 0.61.

Read Our Latest Research Report on NVO

BlackRock (BLK)

BlackRock, Inc. is a publicly owned investment manager. The firm primarily provides its services to institutional, intermediary, and individual investors including corporate, public, union, and industry pension plans, insurance companies, third-party mutual funds, endowments, public institutions, governments, foundations, charities, sovereign wealth funds, corporations, official institutions, and banks.

Shares of NYSE:BLK traded up $12.33 during midday trading on Friday, hitting $928.47. The stock had a trading volume of 822,497 shares, compared to its average volume of 687,353. The stock has a 50 day moving average price of $916.68 and a two-hundred day moving average price of $981.38. The company has a current ratio of 5.23, a quick ratio of 5.23 and a debt-to-equity ratio of 0.45. The company has a market capitalization of $144.15 billion, a PE ratio of 22.11, a P/E/G ratio of 1.90 and a beta of 1.38. BlackRock has a 1 year low of $752.30 and a 1 year high of $1,084.22.

Read Our Latest Research Report on BLK

Blackstone (BX)

Blackstone Inc. is an alternative asset management firm specializing in real estate, private equity, hedge fund solutions, credit, secondary funds of funds, public debt and equity and multi-asset class strategies. The firm typically invests in early-stage companies. It also provide capital markets services.

Shares of Blackstone stock traded up $4.23 on Friday, hitting $137.62. The company's stock had a trading volume of 4,968,025 shares, compared to its average volume of 3,773,954. Blackstone has a 52-week low of $115.66 and a 52-week high of $200.96. The company has a market capitalization of $100.38 billion, a P/E ratio of 37.91, a price-to-earnings-growth ratio of 1.07 and a beta of 1.67. The firm has a fifty day moving average price of $138.89 and a 200-day moving average price of $163.34. The company has a quick ratio of 0.71, a current ratio of 0.67 and a debt-to-equity ratio of 0.61.

Read Our Latest Research Report on BX

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Novo Nordisk A/S Right Now?

Before you consider Novo Nordisk A/S, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novo Nordisk A/S wasn't on the list.

While Novo Nordisk A/S currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Free Today: Your Guide to Smarter Options Trades Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy Early: 3 Tech Trends With Millionaire-Making Potential
5 Stocks to BUY NOW in May 2025
3 Stocks Offering Rare Generational Buying Opportunities

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines